[Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Kölmel
K F
KF
Universitäts-Hautklinik, Göttingen.
Abel
U
U
D004305:Dose-Response Relationship, Drug; D006801:Humans; D015552:Injections, Intralesional; D016899:Interferon-beta / Q000008:administration & dosage*; D008545:Melanoma / Q000628:therapy*; D009362:Neoplasm Metastasis; D011994:Recombinant Proteins / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000628:therapy*
D011994:Recombinant Proteins; D016899:Interferon-beta
Stellungnahme zur Arbeit von G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intraläsionale Therapie von Melanommetastasen mit rekombinantem Interferon-beta.